Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Ongoing symbols : IPHA save search
Innate Pharma Presents Data From Ongoing Phase 2 TELLOMAK Trial Demonstrating Clinical Activity of Lacutamab in Advanced Mycosis Fungoides
Published: 2022-09-23 (Crawled : 06:00) - biospace.com/
SNYNF | News | $92.7 0.63% -2.18% 1.4K
|
Health Technology
|
| O: 5.45%
H: 0.0%
C: -8.46%
NVO | News | $124.53 0.88% 0.19% 2.5M
|
Health Technology
|
| O: -0.53%
H: 0.81%
C: 0.14%
SNY | News | $46.11 0.68% 0.7% 3.5M
|
Health Technology
|
| O: -1.69%
H: 0.0%
C: 0.0%
IPHA | $2.41 -6.95% -10.21% 16K
|
Health Technology
|
| O: -2.02%
H: 0.41%
C: -3.72%
ongoing pharma trial phase 2
Innate Pharma to Present Additional Efficacy Data for Monalizumab in Combination With Cetuximab in Head and Neck Cancer at the ESMO Immuno-Oncology Virtual CongressPhase 2 expansion cohort data supports ongoing Phase 3 trial
Published: 2020-12-03 (Crawled : 15:00) - biospace.com/
IPHA | $2.41 -6.95% -10.21% 16K
|
Health Technology
|
| O: 7.17%
H: 1.27%
C: -3.8%
cancer phase 3 trial expansion ongoing
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
VIAO | $0.262 0.77% 16.03% 14M
|
Electronic Technology
DXF | $0.2708 -5.71% 14.48% 190K
|
Finance
SYTA | $2.9 17.89% 12.77% 300K
|
Non-Energy Minerals
BHIL | $0.1722 -3.8% 12.08% 290K
|
Agriculture, Forestry, Fishing ...
ANVS | $8.99 -10.81% 10.9% 270K
|
Health Technology
AUST | $1.15 -7.26% 8.7% 79K
|
n/a
ATNM | $7.25 -6.33% 8.69% 280K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.